Top news of the week: 17.11.2021.
Companies And Industries
Computed structures of core eukaryotic protein complexes
We take advantage of advances in proteome-wide amino acid coevolution analysis and deep-learning-based structure modeling to systematically identify and build accurate models of …
Sensitive identification of neoantigens and cognate TCRs in human solid tumors
NeoScreen helps identify rare tumor antigens for personalized cancer vaccines and T cell therapies.
Biotech Companies are Expanding the Frontiers of Engineered Cell Therapy
Celares and Mission Bio are part of the rapidly evolving push to create and characterize the superhuman powers cells can be endowed with.
Novartis-partnered DARPin flames out in COVID-19 study, sending Molecular Partners' stock into nosedive
ACTIV-3 has claimed yet another victim. Molecular Partners and Novartis are the latest companies to fail to clear the efficacy bar in the NIH-sponsored COVID-19 study, leaving their hopes ...
Amid crowded migraine market, Lundbeck goes its own way
As its Vyepti migraine therapy starts to gather momentum, Danish pharma company Lundbeck starts mid-stage trials of a new-mechanism drug that could extend its franchise
Listen: Moderna v. NIH, psilocybin as a medicine, & the cultural intake of pharma CEOs
Rebecca Robbins of the New York Times joins us to discuss the escalating tension between Moderna and the NIH over a Covid-19 vaccine.
‘Life as We Made It’ charts the past and future of genetic tinkering
A new book shatters illusions that human meddling with nature has only just begun.
Advancements in Precision Diagnostics: New Regulations and Biomarker Strategies
In this eBook, we explore timely topics in the diagnostics landscape, from regulatory considerations and next-generation COVID-19 diagnostics to an innovative next-generation sequencing ...